EPAP nke imi

Shí Wikipedia, njikotá édémédé nke onyobulạ

Nrụgide ikuku na-esi n'imi apụta (Nasal EPAP) bụ ọgwụgwọ ehighị maka apnea ụra obstructive (OSA) na ịsụ ude.[1][2]

Ngwaọrụ EPAP nke oge a nwere obere valvụ abụọ nke na-enye ohere ka ikuku banye n'ime imi ọ bụla, mana ọ bụghị iku ume; a na ụdị nke ụwa họrọ site na iji bịa na ímé ihe na-ejide valvụ ahụ n'ọnọdụ site na mkpịsị aka na mpụga imi.[1] Usoro nke EPAP nwere ike ịrụ ọrụ edoghị anya; ọ nwere ike ịbụ na iguzogide iku ume imi na-eduga na mkpokọta CO2 nke na-eme ka iku ume na-abawanye, ma ọ bụ na iguzoghachi iku ume na'ime ka nrụgide nke na-amanye ụzọ ikuku dị n'elu imeghe n'ụzọ sara mbara.[1]

Na OSA, o yiri ka ọ dị irè iji belata ma ọ bụghị iwepụ apnea maka ndị nwere OSA dị nro na nke dị nro (Apnea-hypopnea index < 30) na maka ndị na-enweghị ike ịnagide CPAP, mana n'ime ìgwè ndị ahụ, ọ bụghị ihe doro anya na ụdị nke ụwa họrọ site na iji bịa na ímé anya ihe mere ụfọdụ ji emeghachi omume na ndị ọzọ anaghị emeghachi, ihe akaebe ahụ nwere obere nnwale ahụike na-esochi na-agaghị agafe otu afọ.[1][2] Ka ọ na-erule n'afọ 2015, e nwere ihe akaebe sitere n'otu obere nnwale na ọ nwere ike ịba uru na ụmụaka nwere OSA.[1] O gosikwara ihe akaebe nke ibelata ịsụ ude.[1][2]

O yighị ka EPAP ga-arụ ọrụ na ndị nwere nnukwu mgbochi imi.[1] Mmetụta ndị ọzọ pụtara n'oge nnwale ahụike gụnyere nsogbu iku ụtọ nọ n'okpuru nna ha ume, nsogbu ịda ma ọ bụ ịnọ n'ụra, ọnụ kpọrọ nkụ, mgbagwoju anya imi, isi ọwụwa, nsogbu itinye ma ọ bụ wepụ ngwaọrụ ahụ, na nchegbu.[1]

Ventus Medical natara FDA 510K ikike maka ire ahịa ngwaọrụ Provent EPAP maka OSA na 2009.[3][4] Ventus natara ikike 510K maka ngwaọrụ gị na ngalaba ike ịbelata EPAP iji gwọọ ịsụ ngọngọ na June 2012.[5][6] Theravent Inc. nwetara Ventus n'afọ 2013.[7][8]

Ntụaka[dezie | dezie ebe o si]

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Wu (September 2015). "A review of EPAP nasal device therapy for obstructive sleep apnea syndrome.". Sleep & Breathing 19 (3): 769–74. DOI:10.1007/s11325-014-1057-y. PMID 25245174. 
  2. 2.0 2.1 2.2 Riaz (2015). "Nasal Expiratory Positive Airway Pressure Devices (Provent) for OSA: A Systematic Review and Meta-Analysis.". Sleep Disorders 2015: 734798. DOI:10.1155/2015/734798. PMID 26798519. 
  3. FDA ProVent 510K table
  4. FDA Provent 510(k) Summary April 3, 2009
  5. FDA InVent 510K table
  6. FDA InVent 510(k) Summary June 12, 2012
  7. Staff, Sleep Review. April 19, 2013 Ventus Medical Closing Its Doors
  8. Bloomberg Ventus profile Page accessed August 15, 2016

HỊgụ ihe ọzọ[dezie | dezie ebe o si]

  • Calik MW (Apr 2016). "Treatments for Obstructive Sleep Apnea". J Clin Outcomes Manag 23 (4): 181–192. PMID 27134515.